Pharmacia settles Xalatan, Travatan patent cases
Executive Summary
Allergan will pay Pharmacia $120 mil. plus Lumigan product royalties "for a specified time" in Pharmacia Xalatan patent infringement suit settlement, Pharmacia says Oct. 25. Allergan will retain rights to worldwide commercialization of Lumigan. Allergan filed suit against Pharmacia March 1 seeking ruling that Lumigan did not infringe Xalatan patents (1"The Pink Sheet" March 19, p. 29). Pharmacia has also settled with Alcon over patent dispute involving Alcon's Travatan.Alcon will pay royalties on "past and future sales" of Travatan in return for continued unrestricted global marketing, Pharmacia says....